FDMT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - 4D Molecular Therapeutics Inc

Watchlist Manager

Watchlist

Price: 8.69 USD 2.6% Market Closed

Market Cap: $443.6m

	4D Molecular Therapeutics Inc NASDAQ:FDMT	US
	Willis Lease Finance Corp NASDAQ:WLFC	US
B	BJ's Wholesale Club Holdings Inc F:8BJ	US
S	Sasol Ltd JSE:SOL	ZA
T	Tiger Brands Ltd JSE:TBS	ZA
J	JD.Com Inc NASDAQ:JD	CN
G	Great-West Lifeco Inc F:GWS	CA
	United Overseas Australia Ltd ASX:UOS	MY
	Australia and New Zealand Banking Group Ltd ASX:ANZ	AU
W	Warrix Sport PCL SET:WARRIX	TH

Profitability Summary

4D Molecular Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-203%

Negative 3Y Average Operating Margin

-188.337%

Operating Margin is Increasing

-5.148% > -203%

Negative Net Margin

-182%

Negative 3Y Average Net Margin

-164.884%

Net Margin is Increasing

-4.970% > -182%

Negative Free Cash Flow Margin

-147%

Negative 3Y Average Free Cash Flow Margin

-144.289%

Free Cash Flow Margin is Increasing

-4.398% > -147%

Negative ROE

-35%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-226%

ROIC is Increasing

-179% > -121%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.